Researchers at Texas A&M University have developed a nano-sized delivery system that could help bring injected treatments such as insulin into the oral…

Enteris BioPharma, a privately held API company, launched a clinical program for its oral tablet formulation of Tobrate (tobramycin) designed to be used for…

Researchers at Houston Methodist Research Institute were awarded a nearly $4 million grant from the National Institute of Allergy and Infectious Diseases to…

Woburn, MA-based Aphios said it landed a subcontract for the nanoformulation of a new superhydrophobic anticancer drug called Brefeldin A.

The New Jersey Institute of Technology received a $1 million grant from the W. M. Keck Foundation it will use to study new materials for nanotechnology.

Aptuit, a drug discovery and development CRO, has signed a deal with gene therapy player Dimension Therapeutics to support studies for select rare disease…

Researchers at Memorial Sloan Kettering have uncovered a new way to target drugs specifically to cancer sites in the body, including metastatic tumors.

Onxeo, a developer of orphan oncology drugs, is partnering with the Royal College of Surgeons in Ireland (RCSI) as part of a discovery-stage program focused on…

AntriaBio, a biopharma focused on developing novel extended-release therapies, has raised $12 million in a private placement deal.